Career history of Marc E. Uknis
Former positions of Marc E. Uknis
| Companies | Position | Start | End |
|---|---|---|---|
| GEMI THER | Chief Tech/Sci/R&D Officer | 2020-02-29 | 2021-04-10 |
| ACHILLION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2017-12-31 | 2020-01-27 |
Training of Marc E. Uknis
| George Washington University | Masters Business Admin |
Statistics
International
| United States | 4 |
Operational
| Corporate Officer/Principal | 1 |
| Masters Business Admin | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
Achillion Pharmaceuticals, Inc.
 Achillion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Achillion Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of oral small molecule complement system inhibitors. Its pipeline includes Danicopan and ACH-5228. The company was founded on August 17, 1998 and is headquartered in Blue Bell, PA. | Health Technology |
Gemini Therapeutics, Inc.
 Gemini Therapeutics, Inc. BiotechnologyHealth Technology Gemini Therapeutics, Inc. is a clinical-stage precision medicine company. It is developing novel therapeutic compounds to treat genetically defined, age-related macular degeneration. The company was founded by Johanna Seddon, Paul Barlow and Andrew Herbert on March 3, 2015 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Marc E. Uknis
- Experience
